Evidence map›Paper›PMID 22560201›Full record

ArticleBiomaterials2012

Endothelial targeting of polymeric nanoparticles stably labeled with the PET imaging radioisotope iodine-124.

Eric A Simone, Blaine J Zern, Ann-Marie Chacko, John L Mikitsh, Eric R Blankemeyer, Silvia Muro, Radu V Stan, Vladimir R Muzykantov

Abstract read
In one paragraph

Article in Biomaterials, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 35 papers.

0numbers the graph read from it
0cells of the map it votes in
35citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

35 citing papers in PubMed.

  1. TargetedJournal of nanobiotechnology · 2026
    Article
  2. Equip your vehicle for the right terrain: Using features of local pathology to guide engineering of targeted drug delivery systems.Journal of controlled release : official journal of the Controlled Release Society · 2026
    Review
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Review
  9. Review
  10. Review
  11. Article
  12. Pharmacokinetic and Pharmacodynamic Properties of Drug Delivery Systems.The Journal of pharmacology and experimental therapeutics · 2019
    Review
  13. Review
  14. Article
  15. Article
  16. Article
  17. Ferritin-based drug delivery systems: Hybrid nanocarriers for vascular immunotargeting.Journal of controlled release : official journal of the Controlled Release Society · 2018
    Review
  18. Article
  19. Targeting superoxide dismutase to endothelial caveolae profoundly alleviates inflammation caused by endotoxin.Journal of controlled release : official journal of the Controlled Release Society · 2018
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Eric A SimoneInstitute for Translational Medicine and Therapeutics, Perelman School of Medicine, University of Pennsylvania, PA 19104, USA.
Blaine J Zern
Ann-Marie Chacko
John L Mikitsh
Eric R Blankemeyer
Silvia Muro
Radu V Stan
Vladimir R Muzykantov

Funding

Translational Engineering in Cancer (TEC)P30CA023108 · NCI · DARTMOUTH COLLEGE · PI Steven D Leach · 1985 to 2026
$91.3M
Protein CoreP01HL110860 · NHLBI · CHILDREN'S HOSP OF PHILADELPHIA · PI RAUOVA, LUBICA · 2012 to 2016
$11.4M
SUMMER UNDERGRADUATE PROGRAM TO EDUCATE RADIATION SCIENTISTS (SUPERS)R25CA140116 · NCI · UNIVERSITY OF PENNSYLVANIA · PI JAY FITZGERALD DORSEY · 2010 to 2026
$4.1M
Targeting Carriers with Controlled Geometry to EndotheliumR01HL087036 · NHLBI · UNIVERSITY OF PENNSYLVANIA · PI MUZYKANTOV, VLADIMIR R · 2008 to 2012
$2.0M
Cellular/Molecular Mechanisms of Vascular PermeabilityR01HL083249 · NHLBI · DARTMOUTH COLLEGE · PI STAN, RADU VIRGIL · 2006 to 2009
$1.4M
Structure and Function of Endothelial FenestraeR01HL092085 · NHLBI · DARTMOUTH COLLEGE · PI STAN, RADU VIRGIL · 2009 to 2010
$926k
NCI NIH HHS R25 CA140116NHLBI NIH HHS HL-087036-01A2NHLBI NIH HHS P01 HL110860NHLBI NIH HHS R01 HL083249NHLBI NIH HHS R01 HL087036NHLBI NIH HHS R01 HL092085
6 · The paper itself

Abstract

Targeting of therapeutics or imaging agents to the endothelium has the potential to improve specificity and effectiveness of treatment for many diseases. One strategy to achieve this goal is the use of nanoparticles (NPs) targeted to the endothelium by ligands of protein determinants present on this tissue, including cell adhesion molecules, peptidases, and cell receptors. However, detachment of the radiolabel probes from NPs poses a significant problem. In this study, we devised polymeric NPs directly labeled with radioiodine isotopes including the positron emission tomography (PET) isotope (124)I, and characterized their targeting to specific endothelial determinants. This approach provided sizable, targetable probes for specific detection of endothelial surface determinants non-invasively in live animals. Direct conjugation of radiolabel to NPs allowed for stable longitudinal tracking of tissue distribution without label detachment even in an aggressive proteolytic environment. Further, this approach permits tracking of NP pharmacokinetics in real-time and non-invasive imaging of the lung in mice using micro-PET imaging. The use of this strategy will considerably improve investigation of NP interactions with target cells and PET imaging in small animals, which ultimately can aid in the optimization of targeted drug delivery.

Indexed as

NanoparticlesPolyvinylsStaining and LabelingAnimalsAntibodies, MonoclonalDrug Delivery SystemsEndothelial CellsFemaleIodine RadioisotopesLungMiceMice, Inbred C57BLParticle SizePositron-Emission TomographyTime FactorsAntibodies, MonoclonalIodine Radioisotopespoly(4-vinylphenol)Polyvinyls

Identifiers

PMID22560201
PMCPMC3356447

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.